Levetiracetam Lupin (Levetiracetam)

Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in the brain. It is indicated for several seizure disorders:

• Epilepsy: provides overall seizure control across multiple seizure types.
• Partial onset seizures: helps achieve reduction in focal seizure frequency.
• Generalized tonic‑clonic seizures: contributes to prevention of convulsive episodes.
• Myoclonic seizures: assists in decreasing rapid, involuntary muscle jerks.

• Levetiracetam binds to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal membranes. This interaction reduces synaptic excitability, thereby decreasing the likelihood of seizure initiation and propagation throughout the central nervous system.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate in intensity.

Common Side Effects

• Dizziness: transient sensation of light‑headedness.
• Fatigue: feeling unusually tired or weak.
• Somnolence: increased sleepiness during the day.
• Headache: mild to moderate cranial pain.
• Irritability: mood changes or agitation.
• Nausea: upset stomach or feeling of queasiness.

Serious or Rare Side Effects

• Severe allergic reactions: rash, swelling, or anaphylaxis.
• Stevens‑Johnson syndrome: serious skin blistering.
• Blood dyscrasias: abnormal blood counts.
• Suicidal thoughts: emergence of depressive or suicidal ideation.
• Severe skin rash: including toxic epidermal necrolysis.
• Multi‑organ hypersensitivity: systemic inflammatory response.

Before initiating therapy, consider the following safety measures:

• Renal impairment: adjust dose based on renal function.
• Hepatic impairment: monitor liver enzymes and clinical response.
• Pregnancy: limited data; weigh potential benefits against risks.
• Discontinuation: avoid abrupt cessation to reduce seizure rebound.
• Concomitant CNS depressants: may enhance sedation; monitor closely.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Levetiracetam can interact with several medications, requiring attention to dosage and monitoring.

Major Interactions (Avoid)

• Carbamazepine: induces metabolism, lowering levetiracetam levels.
• Phenytoin: reduces levetiracetam plasma concentration.
• Phenobarbital: decreases levetiracetam exposure.
• Rifampin: strong enzyme inducer, markedly reduces levetiracetam.
• Oral contraceptives: may become less effective.

Moderate Interactions (Monitor Closely)

• Valproic acid: may increase levetiracetam concentrations.
• CNS depressants (e.g., benzodiazepines): additive sedation.
• Alcohol: enhances central nervous system effects.
• Lithium: monitor renal function and lithium levels.
• NSAIDs: potential impact on renal clearance.